Evidence map›Paper›PMID 29549390›Full record

ReviewPsychopharmacology2018

Ethanol actions on the ventral tegmental area: novel potential targets on reward pathway neurons.

Chang You, Bertha Vandegrift, Mark S Brodie

Open access · hybridAbstract readReview
In one paragraph

Review in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Clinical GDNF delivery methods for Parkinson's disease.Journal of Parkinson's disease · 2026
    Review
  3. Article
  4. Article
  5. Brain Amylin Signaling, Feeding, and Reward.Comprehensive Physiology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Neural Circuitries and Alcohol Use Disorder: Cutting Corners in the Cycle.Current topics in behavioral neurosciences · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chang YouDepartment of Physiology and Biophysics, University of Illinois at Chicago, 835 S. Wolcott Ave, Room E-202, M/C 901, Chicago, IL, 60612, USA.
Bertha VandegriftDepartment of Physiology and Biophysics, University of Illinois at Chicago, 835 S. Wolcott Ave, Room E-202, M/C 901, Chicago, IL, 60612, USA.
Mark S BrodieDepartment of Physiology and Biophysics, University of Illinois at Chicago, 835 S. Wolcott Ave, Room E-202, M/C 901, Chicago, IL, 60612, USA. mbrodie@uic.edu.ORCID http://orcid.org/0000-0003-3933-561X
University of Illinois Chicago · US

Funding

Pilot Project Program P50AA022538 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBHASH C. PANDEY · 2015 to 2026
$21.3M
Intracellular Study of Ethanol Effects on Brain NeuronsR37AA005846 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI APPEL, SARAH B · 2002 to 2008
$2.7M
INTRACELLULAR STUDY OF ETHANOL EFFECTS ON BRAIN NEURONSR01AA005846 · NIAAA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BRODIE, MARK S · 1985 to 2011
$1.2M
NIAAA NIH HHS P50 AA022538NIAAA NIH HHS R01 AA005846NIAAA NIH HHS R37 AA005846
6 · The paper itself

Abstract

The ventral tegmental area (VTA) evaluates salience of environmental stimuli and provides dopaminergic innervation to many brain areas affected by acute and chronic ethanol exposure. While primarily associated with rewarding and reinforcing stimuli, recent evidence indicates a role for the VTA in aversion as well. Ethanol actions in the VTA may trigger neuroadaptation resulting in reduction of the aversive responses to alcohol and a relative increase in the rewarding responses. In searching for effective pharmacotherapies for the treatment of alcohol abuse and alcoholism, recognition of this imbalance may reveal novel strategies. In addition to conventional receptor/ion channel pharmacotherapies, epigenetic factors that control neuroadaptation to chronic ethanol treatment can be targeted as an avenue for development of therapeutic approaches to restore the balance. Furthermore, when exploring therapies to address reward/aversion imbalance in the action of alcohol in the VTA, sex differences have to be taken into account to ensure effective treatment for both men and women. These principles apply to a VTA-centric approach to therapies, but should hold true when thinking about the overall approach in the development of neuroactive drugs to treat alcohol use disorders. Although the functions of the VTA itself are complex, it is a useful model system to evaluate the reward/aversion imbalance that occurs with ethanol exposure and could be used to provide new leads in the efforts to develop novel drugs to treat alcoholism.

Indexed as

RewardAlcoholismAnimalsCentral Nervous System AgentsDopamineEthanolHumansIon ChannelsNeural PathwaysNeuronsVentral Tegmental AreaCentral Nervous System AgentsDopamineEthanolIon ChannelsAlcoholismDopamineEpigeneticReward/aversionSex differencesVTA

Identifiers

PMID29549390
PMCPMC5949141
OpenAlexW2794319403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.